The human retinal pigment epithelium forms early in development and subsequently remains dormant, undergoing minimal proliferation throughout normal life. Retinal pigment epithelium proliferation, however, can be activated in disease states or by removing retinal pigment epithelial cells into culture. We review the conditions that control retinal pigment epithelial proliferation in culture, in animal models and in human disease and interpret retinal pigment epithelium proliferation in context of the recently discovered retinal pigment epithelium stem cell that is responsible for most in vitro retinal pigment epithelial proliferation. Retinal pigment epithelial proliferation-mediated wound repair that occurs in selected macular diseases is contrasted with retinal pigment epithelial proliferation-mediated fibroblastic scar formation that underlies proliferative vitreoretinopathy. We discuss the role of retinal pigment epithelial proliferation in age-related macular degeneration which is reparative in some cases and destructive in others. Macular retinal pigment epithelium wound repair and regression of choroidal neovascularization are more pronounced in younger than older patients. We discuss the possibility that the limited retinal pigment epithelial proliferation and latent wound repair in older age-related macular degeneration patients can be stimulated to promote disease regression in age-related macular degeneration.
BokD. The retinal pigment epithelium: a versatile partner in vision. J Cell Sci Suppl1993; 17: 189–95.
2.
ZinnKMMarmorMF. The retinal pigment epithelium, Cambridge MA: Harvard University Press, 1979.
3.
StraussO. (2005) The retinal pigment epithelium in visual function. Physiol Rev2005; 85: 845–81.
4.
SparrowJRHicksDHamelCP. The retinal pigment epithelium in health and disease. Curr Mol Med2010; 10: 802–23.
5.
MannI. The development of the human eye, 2nd ed. London: British Medical Association, 1949.
6.
LescheyKHHackettSFSingerJHCampochiaroPA. Growth factor responsiveness of human retinal pigment epithelial cells. Investig Ophthalmol Vis Sci1990; 31: 839–46.
7.
SpraulCWKavenCLangGKLangGE. Effect of growth factors on bovine retinal pigment epithelial cell migration and proliferation. Ophthalmic Res2004; 36: 166–71.
8.
SaleroEBlenkinsopTACorneoBHarrisARabinDSternJHTempleS. Adult human RPE can be activated into a multipotent stem cell that produces mesenchymal derivatives. Cell Stem Cell2012; 10: 88–5.
9.
ShenQGoderieSKJinLKaranthNSunYAbramovaNVincentPPumigliaKTempleS. Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science2004; 304: 1338–40.
10.
MannaghJAryaDVIrvineAR,Jr. Tissue culture of human retinal pigment epithelium. Invest Ophthalmol1973; 12: 52–4.
11.
FloodMTGourasPKjeldbyeH. Growth characteristics and ultrastructure of human retinal pigment epithelium in vitro. Invest Ophthalmol Vis Sci1980; 19: 1309–20.
12.
TamiyaSLiuLKaplanHJ. Epithelial-mesenchymal transition and proliferation of retinal pigment epithelial cells initiated upon loss of cell-cell contact. Invest Ophthalmol Vis Sci2010; 51: 2755–63.
13.
MilyushinaLAKuznetsovaAVGrigoryanENAleksandrovaMA. Phenotypic plasticity of retinal pigment epithelial cells from adult human eye in vitro. Bull Exp Biol Med2011; 151: 506–11.
14.
LiHWangHWangFGuQXuX. Snail involves in the transforming growth factor beta1-mediated epithelial-mesenchymal transition of retinal pigment epithelial cells. PLoS One2011; 6: e23322–e23322.
15.
HuJBokD. A cell culture medium that supports the differentiation of human retinal pigment epithelium into functionally polarized monolayers. Mol Vis2001; 7: 14–9.
16.
MaminishkisAChenSJalickeeSBanzonTShiGWangFEEhaltTHammerJAMillerSS. Confluent monolayers of cultured human fetal retinal pigment epithelium exhibit morphology and physiology of native tissue. Invest Ophthalmol Vis Sci2006; 47: 3612–24.
17.
GammDMMelvanJNShearerRLPinillaISabatGSvendsenCNWrightLS. A novel serum-free method for culturing human prenatal retinal pigment epithelial cells. Invest Ophthalmol Vis Sci2008; 49: 788–99.
18.
IdelsonMAlperRObolenskyABen-ShushanEHemoIYachimovich-CohenNKhanerHSmithYWiserOGroppMCohenMAEven-RamSBerman-ZakenYMatzrafiLRechaviGBaninEReubinoffB. Directed differentiation of human embryonic stem cells into functional retinal pigment epithelium cells. Cell Stem Cell2009; 5: 396–8.
19.
BlenkinsopTASaleroESternJHTempleS. The culture and maintenance of functional retinal pigment epithelial monolayers from adult human eye. Methods Mol Biol2013; 945: 45–5.
20.
KaidaMCaoFSkumatzCMIrvingPEBurkeJM. Time at confluence for human RPE cells: effects on the adherens junction and in vitro wound closure. Invest Ophthalmol Vis Sci2000; 41: 3215–24.
21.
ZhangWLiuHT. MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res2002; 12: 9–18.
22.
HecquetCLefevreGValtinkMEngelmannKMascarelliF. Activation and role of MAP kinase-dependent pathways in retinal pigment epithelial cells: ERK and RPE cell proliferation. Invest Ophthalmol Vis Sci2002; 43: 3091–98.
23.
BhartiKNguyenMTSkuntzSBertuzziSArnheiterH. The other pigment cell: specification and development of the pigmented epithelium of the vertebrate eye. Pigment Cell Res2006; 19: 380–94.
24.
WangHNinomiyaYSuginoIKZarbinMA. Retinal pigment epithelium wound healing in human Bruch's membrane explants. Invest Ophthalmol Vis Sci2003; 44: 2199–10.
25.
LiRMaminishkisAZahnGVossmeyerDMillerSS. Integrin alpha5beta1 mediates attachment, migration, and proliferation in human retinal pigment epithelium: relevance for proliferative retinal disease. Invest Ophthalmol Vis Sci2009; 50: 5988–96.
26.
StanzelBVEspanaEMGrueterichMKawakitaTParelJMTsengSCBinderS. Amniotic membrane maintains the phenotype of rabbit retinal pigment epithelial cells in culture. Exp Eye Res2005; 80: 103–2.
27.
LutolfMPHubbellJA. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol2005; 23: 47–5.
28.
GullapalliVKSuginoIKVan PattenYShahSZarbinMA. Impaired RPE survival on aged submacular human Bruch's membrane. Exp Eye Res2005; 80: 235–48.
29.
TezelTHDel PrioreLVKaplanHJ. Reengineering of aged Bruch's me mbrane to enhance retinal pigment epithelium repopulation. Invest Ophthalmol Vis Sci2004; 45: 3337–48.
30.
WangHVan PattenYSuginoIKZarbinMA. Migration and proliferation of retinal pigment epithelium on extracellular matrix ligands. J Rehabil Res Dev2006; 43: 713–22.
31.
HellerJPMartinKR. Enhancing RPE cell-based therapy outcomes for AMD: the role of bruch's membrane. Transl Vis Sci Technol2014; 3: 11–11.
32.
GullapalliVKSuginoIKVan PattenYShahSZarbinMA. Retinal pigment epithelium resurfacing of aged submacular human Bruch's membrane. Trans Am Ophthalmol Soc2004; 102: 123–37;discussion 137–28.
33.
SuginoIKSunQCheewatrakoolpongNMalcuitCZarbinMA. Biochemical restoration of aged human Bruch's membrane: experimental studies to improve retinal pigment epithelium transplant survival and differentiation. Dev Ophthalmol2014; 53: 133–42.
34.
ZarbinMA. Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol2004; 122: 598–14.
35.
VerstraetenTCBuzneySMMacdonaldSGNeufeldAH. Retinal pigment epithelium wound closure in vitro. Pharmacologic inhibition. Invest Ophthalmol Vis Sci1990; 31: 481–88.
36.
RabinDMRabinRLBlenkinsopTATempleSSternJH. Chronic oxidative stress upregulates Drusen-related protein expression in adult human RPE stem cell-derived RPE cells: a novel culture model for dry AMD. Aging (Albany NY)2013; 5: 51–6.
37.
DeSRabinDMSaleroELedermanPLTempleSSternJH. Human retinal pigment epithelium cell changes and expression of alphaB-crystallin: a biomarker for retinal pigment epithelium cell change in age-related macular degeneration. Arch Ophthalmol2007; 125: 641–45.
BhartiKMillerSSArnheiterH. The new paradigm: retinal pigment epithelium cells generated from embryonic or induced pluripotent stem cells. Pigment Cell Melanoma Res2011; 24: 21–4.
41.
KurodaTYasudaSKusakawaSHirataNKandaYSuzukiKTakahashiMNishikawaSKawamataSSatoY. Highly sensitive in vitro methods for detection of residual undifferentiated cells in retinal pigment epithelial cells derived from human iPS cells. PLoS One2012; 7: e37342–e37342.
42.
BuchholzDEPenningtonBOCrozeRHHinmanCRCoffeyPJCleggDO. Rapid and efficient directed differentiation of human pluripotent stem cells into retinal pigmented epithelium. Stem Cells Transl Med2013; 2: 384–93.
Del PrioreLVHornbeckRKaplanHJJonesZValentinoTLMosinger-OgilvieJSwinnM. Debridement of the pig retinal pigment epithelium in vivo. Arch Ophthalmol1995; 113: 939–44.
45.
StroevaOGMitashovVI. Retinal pigment epithelium: proliferation and differentiation during development and regeneration. Int Rev Cytol1983; 83: 221–93.
46.
KeefeJR. An analysis of urodelian retinal regeneration. IV. Studies of the cellular source of retinal regeneration in Triturus cristatus carnifex using 3 H-thymidine. J Exp Zool1973; 184: 239–58.
47.
HasegawaM. Restitution of the eye after removal of the retina and lens in the newt triturus pyrrhogaster. Embryologia1958; 4: 1–32.
48.
Casaroli-MaranoRPPaganRVilaroS. Epithelial-mesenchymal transition in proliferative vitreoretinopathy: intermediate filament protein expression in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci1999; 40: 2062–72.
49.
BhartiKMillerSSArnheiterH. The new paradigm: retinal pigment epithelium cells generated from embryonic or induced pluripotent stem cells. Pigment Cell Melanoma Res2011; 24: 21–34.
50.
SchwartzSDHubschmanJPHeilwellGFranco-CardenasVPanCKOstrickRMMickunasEGayRKlimanskayaILanzaR. Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet2012; 379: 713–20.
51.
AssawachananontJMandaiMOkamotoSYamadaCEirakuMYonemuraSSasaiYTakahashiM. Transplantation of embryonic and induced pluripotent stem cell-derived 3D retinal sheets into retinal degenerative mice. Stem Cell Reports2014; 2: 662–74.
52.
CarrAJSmartMJRamsdenCMPownerMBda CruzLCoffeyPJ. Development of human embryonic stem cell therapies for age-related macular degeneration. Trends Neurosci2013; 36: 385–95.
SchwartzSDRegilloCDLamBLEliottDRosenfeldPJGregoriNZHubschmanJPDavisJLHeilwellGSpirnMMaguireJGayRBatemanJOstrickRMMorrisDVincentMAngladeEDel PrioreLVLanzaR. Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies. Lancet. 2014: 509–516.
55.
BresslerNMSilvaJCBresslerSBFineSLGreenWR. Clinicopathologic correlation of drusen and retinal pigment epithelial abnormalities in age-related macular degeneration. Retina1994; 14: 130–42.
FlanneryJGFarberDBBirdACBoD. Degenerative changes in a retina affected with autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci1989; 30: 191–11.
58.
PeirettiEIranmaneshRLeeJJKlancnikJM,Jr.SorensonJAYannuzziLA. Repopulation of the retinal pigment epithelium after pigment epithelial rip. Retina2006; 26: 1097–99.
59.
MachemerRLaquaH. Pigment epithelium proliferation in retinal detachment (massive periretinal proliferation). Am J Ophthalmol1975; 80: 1–23.
60.
AndersonDHSternWHFisherSKEricksonPABorgulaGA. The onset of pigment epithelial proliferation after retinal detachment. Invest Ophthalmol Vis Sci1981; 21: 10–6.
GassJD. Stereoscopic atlas of macular disease1997; Vol. 4. Mosby, St. Louis, pp. 26–105.
66.
GreenWR. Histopathology of age-related macular degeneration. Mol Vis1999; 5: 27–27.
67.
WallowIHTsoMOFineBS. Retinal repair after experimental xenon arc photocoagulation. I. A comparison between rhesus monkey and rabbit. Am J Ophthalmol1973; 75: 32–2.
68.
RyanSJ. The development of an experimental model of subretinal neovascularization in disciform macular degeneration. Trans Am Ophthalmol Soc1979; 77: 707–45.
69.
DobiETPuliafitoCADestroM. A new model of experimental choroidal neovascularization in the rat. Arch Ophthalmol1989; 107: 264–69.
70.
MillerHMillerBIshibashiTRyanSJ. Pathogenesis of laser-induced choroidal subretinal neovascularization. Invest Ophthalmol Vis Sci1990; 31: 899–08.
71.
GrossniklausHEGreenWR. Histopathologic and ultrastructural findings of surgically excised choroidal neovascularization. Submacular surgery trials research group. Arch Ophthalmol1998; 116: 745–49.
72.
GassJD. Biomicroscopic and histopathologic considerations regarding the feasibility of surgical excision of subfoveal neovascular membranes. Trans Am Ophthalmol Soc1994; 92: 91–11;discussion 111–16.
73.
CampochiaroPAMorganKMConwayBPStathosJ. Spontaneous involution of subfoveal neovascularization. Am J Ophthalmol199; 109: 668–75.
74.
AvilaMPWeiterJJJalkhAETrempeCLPruettRCSchepensCL. Natural history of choroidal neovascularization in degenerative myopia. Ophthalmology1984; 91: 1573–81.
75.
KleinerRCRatnerCMEngerCFineSL. Subfoveal neovascularization in the ocular histoplasmosis syndrome. A natural history study. Retina1988; 8: 225–29.
76.
VelosoCECostaRAOreficeJLOreficeF. Spontaneous involution of choroidal neovascularization secondary to rubella retinopathy. Eye (Lond)2007; 21: 1429–30.
77.
SternJEvelethDMasulaJTempleS. Slow progression of exudative age related macular degeneration associated with hypertrophy of the retinal pigment epithelium. F1000Res2014; 3: 293–293.
